Focusing on prostate cancer, the new chapter of ‘Jaanta
MediBuddy, India’s largest digital healthcare company, today announced the launch
More than 50 digital health services/ applications integrated with Ayushman Bharat Digital Mission (ABDM)
The National Health Authority (NHA) announced expansion of the digital health ecosystem being built under its flagship scheme Ayushman Bharat Digital Mission (ABDM) with
Made in India technology of Near-Infrared Imaging(NIFI) used for the first time in India for thyroid surgery by the CK Birla Hospital®
Furthering the commitment to strengthening delivery of global standards of clinical excellence, the CK Birla Hospital®, recently treated a 59-year-old male patient for large
Rela Hospitals Onboard Augnito as Voice AI partners.
In an Enterprise-wide roll out, Rela Hospital, Chennai has onboarded Augnito AI as the tech enablers for its doctors across the spectrum. Augnito is
Fujifilm India partners with Indian Cancer Society for “Cancer Mukt Dilli” campaign
• Under the campaign, 1000 individuals will be screened for different types of Cancer, and select people will be financially supported • Each camp in Delhi NCR
YOUNGEST PATIENT IN INDIA UNDERGOES REMOVAL OF OBSTRUCTION IN FOOD PIPE BY SPECIAL ENDOSCOPIC PROCEDURE CALLED POEM (PER ORAL ENDOSCOPIC MYOTOMY)
“The challenge for us was to do this novel procedure in such a low weight child of this young age of 6 years (one
First Indian Opthalmologist In Asia Pacific Region To Be Selected For Arthur Lim Award By Asia Pacific Academy Of Ophthalmology
Professor A.K.Grover , Chairperson, Department of Opthalmology, Sir Ganga Ram Hospital Prof. A.K Grover , Chairperson, Department of Opthalmology, Sir
Clove Dental launches Students’ Dental Plan to spread smiles and bring confidence amongst students for their new beginning
A first-of-its-kind dental plan specially curated for the students passing out the board exams Clove Dental, the largest network of dental clinics in India, is
MedGenome Labs now offering clonoSEQ® Assay in India
clonoSEQ is the 1st U. S. Food and Drug Administration (FDA) cleared MRD test for Multiple Myeloma, Chronic Lymphoblastic Leukaemia (CLL), and B-Acute Lymphoblastic